Upregulated Solute Carrier SLC39A1 Promotes Gastric Cancer Proliferation and Indicates Unfavorable Prognosis

Table 2

Kaplan–Meier overall survival (OS) analyses.

Characteristic	Case (n = 154)	Median OS (months)	5-year OS (%)	-value
Age
≤60 yrs	64	27.0	33.3	0.759
>60 yrs	90	34.0	33.5
Sex
Female	43	33.0	42.4	0.850
Male	111	33.0	29.7
Localization
Upper 1/3	85	35.0	31.1	0.446
Lower 2/3	69	27.0	34.9
Tumor diameter
≤5.0 cm	109	55.0	43.1	0.003
>5.0 cm	45	19.0	22.6
Differentiation
Well/moderate	56	57.0	43.6	0.114
Poor	98	32.0	28.2
T stage
T1/T2	58	57.0	46.4	0.002
T3/T4	96	24.0	26.1
LN metastasis
Negative	54	60.0	47.9	0.001
Positive	100	23.0	25.3
SLC39A1 protein level
Low	77	57.0	49.0	0.001
High	77	22.0	21.2